Variable | All patients (n = 41) | Patients without sarcopenia (n = 17) | Patients with sarcopenia (n = 24) | P value |
---|---|---|---|---|
Sociodemographic data: | ||||
Age, years | 44.18 ± 13.11 | 42.35 ± 8.57 | 45.47 ± 15.61 | 0.418* |
Gender: | Â | Â | Â | 0.812*** |
Male | 25(61%) | 10(58.8%) | 15(62.5%) | Â |
Female | 16(39%) | 7(41.2%) | 9(37.5%) | Â |
Marital status: | Â | Â | Â | 0.056*** |
Married | 32(78%) | 16(94.1%) | 16(66.7%) | Â |
Non-married | 9(22%) | 1(5.9%) | 8(33.3%) | Â |
Associated comorbidities: | ||||
DM | 2(4.9%) | 1(5.9%) | 1(4.2%) | 1*** |
HTN | 27(65.9%) | 13(76.5%) | 14(58.3%) | 0.228*** |
HD duration, months | 48(6-170) | 48(12–122) | 54(6-170) | 0.404** |
Laboratory data: | ||||
Blood hemoglobin, gm/dl | 10.27 ± 1.44 | 10.61 ± 0.98 | 10.03 ± 1.67 | 0.176* |
Serum albumin, gm/dl | 3.99 ± 0.38 | 4.10 ± 0.39 | 3.91 ± 0.35 | 0.122* |
Serum calcium, mg/dl | 8.19 ± 0.82 | 8.46 ± 0.80 | 8 ± 0.79 | 0.084* |
Serum phosphorus, mg/dl | 5.32 ± 1.74 | 5 ± 1.75 | 5.54 ± 1.73 | 0.343* |
iPTH, pg/mL | 405(6.8–1559) | 455(6.8–1559) | 370(47.40–1467) | 0.653** |
Serum ferritin, ng/mL | 282.6(5-1203) | 374(32.6–1018) | 221.5(5-1203) | 0.296** |
URR, % | 60.88 ± 8.20 | 58.80 ± 7.92 | 62.61 ± 8.25 | 0.189* |
Kt/V | 1.16 ± 0.28 | 1.10 ± 0.24 | 1.22 ± 0.31 | 0.212* |